Resonant Pharmaceuticals Private Limited

Resonant Pharmaceuticals Private Limited - pharma in Navagam, Gujarat, India. FY 2026 financials & compliance.
CIN U24100GJ2014PTC081345 Incorporated 26 November 2014 ROC Ahmedabad HQ Navagam, Gujarat, India
Active Private Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹14.67 Cr
▲ 81% YoY
Net loss · FY 2025
₹1.25 Cr
Net margin -8.5%
EBITDA · FY 2025
₹33.71 Lakh
EBITDA margin 2.3%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹5 Cr
Issued & subscribed
Open charges
₹3.02 Cr
Satisfied ₹5 Cr
Company age
12 yrs
Est. 2014
Employees · EPFO
69
Provident fund records

About Resonant Pharmaceuticals Private Limited

Data last updated:

Resonant Pharmaceuticals Private Limited is a private limited company based in Navagam, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 November 2014 and has been in existence for over 12 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24100GJ2014PTC081345. Its GSTIN is 24AAHCR1044H1ZO (Gujarat).

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹5 Cr. It is led by directors including Sagar Shashikant Shah and Jay Dipak Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No. 430 – 1 – A Near Saffron Color Factory Village – Navagam. Taluka – Kheda Distict – K, Heda, Gujarat, India – 387620.

As per the financials filed for FY 2025, the company reported a revenue of ₹14.67 Cr, a growth of 81% compared to the previous year. For the same year it recorded a net loss of ₹1.25 Cr (net margin -8.5%) and EBITDA of ₹33.71 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 54% over three years and 69% over five years.

The company has about 69 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Resonant Pharmaceuticals. As per MCA filings, the company has open charges of ₹3.02 Cr and satisfied charges of ₹5 Cr on record.

Resonant Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-12-0006671). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website resonantpharma.com.

Company details

CIN U24100GJ2014PTC081345
Registration Number 081345
Incorporation Date 26 November 2014
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-12-0006671

Recognitions & Rankings of Resonant Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-12-0006671

Contact details

Resonant Pharmaceuticals Private Limited's registered office is in Navagam, Gujarat. Its website is resonantpharma.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    Plot No. 430 – 1 – A Near Saffron Color Factory Village – Navagam. Taluka – Kheda Distict – K, Heda, Gujarat, India – 387620
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Resonant Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Resonant Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Resonant Pharmaceuticals operates one associated brand: Resonant Pharmaceuticals. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures pharmaceutical products, offers research, consulting, and manufacturing services globally.resonantpharma.com

Business activity

The main business activity of Resonant Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Resonant Pharmaceuticals Private Limited, buy the company report.

Financials of Resonant Pharmaceuticals Private Limited

FY 2025 filings available

Resonant Pharmaceuticals Private Limited reported revenue of ₹14.67 Cr (up 81% YoY) for FY 2025.

Revenue · FY 2025
₹14.67 Cr ▲ 81%
Net loss · FY 2025
₹1.25 Cr margin -8.5%
EBITDA · FY 2025
₹33.71 Lakh margin 2.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 81%
3 years · compounded
▲ 54%
5 years · compounded
▲ 69%
EBITDA CAGR growth
1 year
▲ 142%
3 years · compounded
▲ 30%
5 years · compounded
▲ 6%

Revenue has grown at a compounded annual rate (CAGR) of 69% over five years, including 81% growth in the latest year. EBITDA rose 142% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹33.71 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹1.25 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin2.3%
Net Profit Margin-8.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Resonant Pharmaceuticals Private Limited, buy the company report.

Board of directors of Resonant Pharmaceuticals Private Limited

Resonant Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Sagar Shashikant ShahDirector26 Nov 201411 Years 11 MonthsCurrent
Jay Dipak PatelDirector26 Nov 201411 Years 11 MonthsCurrent
Ankit Deepak BhargavaDirector26 Nov 201411 Years 11 MonthsCurrent
Birju Rajendra ShahDirector26 Nov 201411 Years 11 MonthsCurrent

Peer comparison

Resonant Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
BKRS Pharma Private Limited₹14.8 Cr (FY 2025)-15.0%Gurgaon, Haryana, India
Adonis Phytoceuticals Private Limited₹14.78 Cr (FY 2025)17.0%New Delhi, Delhi, India
Prospect Pharmaceuticals Private Limited₹14.78 Cr (FY 2024)18.0%Bishnupur, West Bengal, India
Resonant Pharmaceuticals Private Limitedthis company₹14.67 Cr (FY 2025)-₹1.25 Cr-8.5%81.0%69Navagam, Gujarat, India
Auftritt Healthcare Private Limited₹14.66 Cr (FY 2023)37.0%Pune, Maharashtra, India

To see the full peer comparison of Resonant Pharmaceuticals Private Limited, buy the company report.

Auditor

Resonant Pharmaceuticals Private Limited is audited by V K JINDAL & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
V K JINDAL & COFY 2023001468C

Shareholding

The shareholding of Resonant Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Resonant Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹3.02 Cr
Satisfied charges
₹5 Cr
Breakdown by lending institutions
Others₹3.02 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
31 Jan 2024100879259Others₹2.25 CrOpen
31 Jan 2024100879226Others₹76.8 LakhOpen
02 Nov 2021100496094Sidbi₹1.5 CrSatisfied
17 Jun 2020100341717Sidbi₹3.5 CrSatisfied

To see the full charge records of Resonant Pharmaceuticals Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Resonant Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Resonant Pharmaceuticals Private Limited has a workforce of 69 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
69
Active EPFO establishments
1
Employee growth
27.78%

GST

Resonant Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAHCR1044H1ZOGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Resonant Pharmaceuticals Private Limited, buy the company report.

Recent activity

Resonant Pharmaceuticals Private Limited has 4 board changes on record since 2014: 4 appointments. The latest: Ankit Deepak Bhargava was appointed as Director on 26 Nov 2014.

AGM
Resonant Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Resonant Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 02 Nov 2021 via Charge ID 100496094 with Sidbi was fully satisfied on 07 Mar 2024.
Charges
A charge registered on 17 Jun 2020 via Charge ID 100341717 with Sidbi was fully satisfied on 06 Mar 2024.
Charges
A charge with Others amounted to Rs. 2.25 Cr with Charge ID 100879259 was registered on 31 Jan 2024.
Charges
A charge with Others amounted to Rs. 0.77 Cr with Charge ID 100879226 was registered on 31 Jan 2024.
Charges
A charge with Sidbi amounted to Rs. 1.50 Cr with Charge ID 100496094 was registered on 02 Nov 2021.
Charges
A charge with Sidbi amounted to Rs. 3.50 Cr with Charge ID 100341717 was registered on 17 Jun 2020.
Appointed
Ankit Deepak Bhargava was appointed as Director.
Appointed
Birju Rajendra Shah was appointed as Director.
Appointed
Jay Dipak Patel was appointed as Director.
Appointed
Sagar Shashikant Shah was appointed as Director.

1 earlier event is in the company report.

Frequently asked questions

Resonant Pharmaceuticals is an active private limited company based in Navagam, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 November 2014 (12+ years old) and is registered under CIN U24100GJ2014PTC081345.

Resonant Pharmaceuticals has 4 current directors:

The latest financial statements of Resonant Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Resonant Pharmaceuticals is 24AAHCR1044H1ZO, registered in Gujarat.

The CIN (Corporate Identification Number) of Resonant Pharmaceuticals is U24100GJ2014PTC081345. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Resonant Pharmaceuticals was incorporated on 26 November 2014, making it 12+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Resonant Pharmaceuticals by revenue are BKRS Pharma Private Limited, Adonis Phytoceuticals Private Limited, Prospect Pharmaceuticals Private Limited, Auftritt Healthcare Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).

Ankit Deepak Bhargava was appointed as Director on 26 Nov 2014. Birju Rajendra Shah was appointed as Director on 26 Nov 2014. Jay Dipak Patel was appointed as Director on 26 Nov 2014. Resonant Pharmaceuticals has 4 board changes on record in total.

Yes, Resonant Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-12-0006671).

Resonant Pharmaceuticals can be reached through the website resonantpharma.com. Its registered office is in Navagam, Gujarat, India.

The registered office of Resonant Pharmaceuticals is at Plot No. 430 – 1 – A Near Saffron Color Factory Village – Navagam. Taluka – Kheda Distict – K, Heda, Gujarat, India – 387620.